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Edited by Varda RotterAbstract Diabetic nephropathy (DN) is one of the main causes
of end stage renal disease (ESRD) and a leading cause of diabe-
tes mellitus related morbidity and mortality. Recently, sirtuin are
reported to have emerging pathogenetic roles in cancer, muscle
diﬀerentiation, heart failure, neurodegeneration, diabetes and
aging. The aim of the present study was to study the role of inter-
mittent fasting (IF) on DN and studying the expression of Sir2
and p53. At biochemical level, we found that IF causes signiﬁcant
improvement in blood urea nitrogen (BUN), creatinine, albumin
and HDL cholesterol, parameters that are associated with the
development of DN. Diabetic rats on IF also show signiﬁcant
improvement in onset of hypertension. Interestingly, the expres-
sion of Sir2, a NAD dependent histone deacetylase, decreases in
diabetic rat kidney and this decrease is overcome by IF. More-
over, we provide evidence for involvement of mitogen activated
protein kinases (MAPK) cascade in mediating the eﬀects of IF
as there is reduction in the expression of p38 which gets induced
under diabetic condition. This was further accompanied by the
concomitant decrease in cleavage of caspase3 and p53 expres-
sion. These ﬁndings suggest that IF signiﬁcantly improves bio-
chemical parameters associated with development of DN and
changes the expression of Sir2 and p53.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Dietary restriction (DR) can reduce body weight and nor-
malize blood glucose, insulin, and leptin levels in obese animals
and humans [1]. It also increases both the mean and maximum
lifespan of rodents, and this antiaging eﬀect is associated with
enhanced insulin sensitivity [2]. To increase life span two diﬀer-Abbreviations: IF, intermittent fasting; DN, diabetic nephropathy;
MDA, malondialdehyde; SOD, superoxide dismutase; STZ, strepto-
zotocin; DR, dietary restriction; CR, calorie restriction; BUN, blood
urea nitrogen; Sir2, silent information regulator 2; MAPK, mitogen
activated protein kinase
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doi:10.1016/j.febslet.2007.02.006ent paradigms of DR have been widely employed in rats and
mice. In one paradigm, the animals receive food daily but
are limited to a speciﬁc amount, which is typically 30–40% less
than the ad libitum (AL) consumption of the control group.
The second paradigm involves intermittent fasting (IF) in
which the animals are deprived of food for a full day, every
other day, and are fed AL on the intervening days. There are
several possible molecular mechanisms that might explain the
beneﬁcial eﬀects of DR on aging and disease including reduc-
tion in mitochondrial oxyradical production, induction of a
cytoprotective cellular stress response, and stimulation of the
production of growth factors [2–4].
DR reduces tumor formation, kidney diseases and increases
the resistance of neurons to dysfunction and degeneration in
experimental models of Alzheimer’s and Parkinson’s diseases
as well as in stroke. It is known that IF without an overall
reduction in calorie intake exerts several beneﬁcial eﬀects such
as lifespan extension, improved glucose regulation and neuro-
protection [5]. IF and calorie restriction (CR) increases insulin
sensitivity that results in reduced plasma glucose and improved
glucose tolerance [6]. It is not only known to reduce the oxida-
tive stress [2] but also increases cellular resistance to various
type of stress and enhances immune functions [3].
Diabetic nephropathy (DN) is the leading cause of ESRD
resulting in diabetes related morbidity and mortality [7]. It is
associated with protein that eventually spills into the urine
(proteinurea) because of damaged or destroyed ﬁlters, and
when the entire ﬁltration system breaks down, the kidneys fail
to function. DN also refers to the glomerular lesions, glomer-
ular basement membrane thickening, diﬀuse mesangial matrix
increase, nodular mesangial matrix increase, mesangial, endo-
thelial cell proliferation, arteriolar lesions, and tubular cell
problems [8,9]. There is signiﬁcant increase in apoptosis in
the tubular and interstitial cells during the course of progres-
sion of diabetic nephropathy [10,11]. Stress-activated signaling
pathways such as nuclear factor-jB, p38 mitogen activated
protein kinase (MAPK), and Jun kinases underlie the develop-
ment of diabetic complications [12]. It has also been reported
previously that high glucose levels can activate the p38 MAPK
pathway in many cell types, including renal cells [13,14].
Recently, sirtuins are reported to have pathogenetic role in
cancer, muscle diﬀerentiation, heart failure, neurodegenera-
tion, diabetes and aging. Silent information regulator 2
(Sir2)-family proteins (sirtuins) are Class III protein deacety-
lases conserved from prokaryotes to mammals. Sir2 orthologs
also have been shown to promote longevity in yeast, worm andblished by Elsevier B.V. All rights reserved.
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tionarily conserved regulators of aging [15]. SIRT1 is a mam-
malian homolog of the Saccharomyces cerevisiae chromatin
silencing factor Sir2. Sirtuins have also been implicated in sev-
eral important cellular processes, including transcriptional
silencing, genomic stability, DNA repair, adipogenesis and
p53-mediated apoptosis [16]. Complex role of p53 in SIRT1
regulation has been suggested. Higher basal expression of
SIRT1 in adipose tissue was observed in p53/ mice than in
wild type control. These in vivo results support role for p53
in SIRT1 regulation [17]. Moreover not much is known that
whether IF can protect or delay the development of diabetic
nephropathy. In the present study, we have tested the hypoth-
esis that IF can improve physiological and biochemical param-
eters associated with diabetic nephropathy.2. Materials and methods
2.1. Chemical
All the chemicals were purchased from Sigma (St. Louis, MO,
USA), unless otherwise mentioned. Plasma glucose level, blood urea
nitrogen (BUN), plasma albumin and plasma HDL-cholesterol were
estimated by commercially available kits.
2.2. Animal treatment and development of diabetic nephropathy
All the experiments were approved by the Institutional Animal Eth-
ics Committee (IAEC) and complied with the NIH guidelines on han-
dling of experimental animals. Experiments were performed on male
Sprague–Dawley rats in the weight range of 240–260 g which were pro-
cured from the central animal facility of the institute, kept at con-
trolled environmental conditions with room temperature 22 ± 2 C
and 12 h light/dark cycles. After one week of acclimatization, animals
were divided into four diﬀerent groups namely: control ad libitum
(CAL), control IF (CIF), provided access to food every other day, dia-
betic ad libitum (DAL) and diabetic IF (DIF), provided access to food
every other day. Animals were kept in the mesh bottom cages to pre-
vent the caphrophagy and for accurate estimation of spillage [6].
Diabetes was induced by injecting streptozotocin (STZ)
(55 mg kg1, i.p. dissolved in ice cold sodium citrate buﬀer, 0.01 M,
pH 4.4). Animals with plasma glucose level >250 mg/dL after 48 h post
induction of diabetes were included in the study as diabetic animals
[18]. Age matched control rat received sodium citrate buﬀer. The ani-
mals of group CIF and DIF were kept on IF, i.e. alternate day fasting
and full access of food was provided to CAL and DAL for 8 weeks.
DN was evaluated by checking biochemical parameters like plasma
creatinine, plasma albumin and BUN.
2.3. Measurement of body weight and food intake
Body weight was measured each week while food intake was mea-
sured daily. To keep track of spillage white bedding was used to allow
easy separation of unconsumed food and powder from waste and bed-
ding; spilled food was allowed to dry fully to avoid measurement of
wet weight added by urine [6].
2.4. Blood pressure recording
Blood pressure (systolic, mean and diastolic) and heart rate was re-
corded at 8th week post-STZ administration, using a tail cuﬀ blood
pressure recorder (IITC INC, Life Science Instruments, Model no.
29,229; CA, USA). Rats were acclimatized up to one week in heating
chamber (24–26 C) for 20 min before recording the blood pressure
(between 9 AM and 11 AM). Blood pressure was measured for each
rat and the average was calculated [18].
2.5. Measurement of biochemical parameters
Blood samples were collected from the retro orbital plexus of rats
under light ether anesthesia in heparinized centrifuge tubes and imme-
diately centrifuged at 2300g for the separation of plasma. Plasma was
stored at 80 until assayed. The plasma was used for the estimation
of glucose, HDL cholesterol, albumin and BUN. Estimations were car-ried out as per manufacturer’s instruction provided with commercially
available kits. Plasma creatinine concentration was measured by the
picric acid colorimetric method [19].
2.6. Measurement of lipid peroxidation and superoxide dismutase
(SOD) activity
The lipid peroxide level in animal tissues was measured according to
method described by Ohkawa et al. [20]. SOD activity was estimated
according to method described by Paoletti et al. [21].
2.7. Histopathology of kidney
Rats were anesthetized under light ether anesthesia, after surgery cir-
culating blood was removed by cardiac perfusion with 0.1 M PBS (pH
7.4; 20–50 ml). After clearance of circulating blood, 4% paraformalde-
hyde in 0.1 M phosphate buﬀer (pH 7.4) was perfused for another
5 min (100–200 ml of ﬁxative) to ﬁx the tissues. Kidneys were removed
from the animal, decapsulated, sliced transversely, and paraﬃn-
embedded for light microscopic evaluation. Histopathological changes
in kidney structure were assessed in at least 25 randomly selected tissue
sections from each group studied. Sections were stained with Mayer’s
hematoxylin and eosin to examine cell structure.
2.8. Protein isolation and Western blotting
Total proteins were isolated from kidney tissue homogenates by
sonication and nuclei were isolated according to method described
by Tikoo et al. [22]. Histones were acid extracted using 0.25 M HCl.
Nuclei were suspended in buﬀer [1% NP-40,10 mM Tris, 10 mM NaCl,
10 mM EDTA, 10 lg/ml aprotinin, 10 lg/ml leupeptin, and 1 mM
phenylmethanesulfonyl ﬂuoride (PMSF)] prior to sonication and its
protein concentration was determined by Lowry method [23].
For Western blot analysis, proteins were transferred onto nitrocellu-
lose membrane and immunoblot analysis was performed by using the
Anti p38 (rabbit polyclonal 1:500, Santa Cruz), Anti p53 (mouse
monoclonal, 10 lg/ml, Calbiochem), Anti Sir2 (rabbit polyclonal
1:500, Sigma), Anti-actin (rabbit 1:2500, Santa Cruz), p-Histone H3
ser-10 (rabbit 1:2000, Santa Cruz), Anti Caspase-3 (rabbit 1:1000, Cal-
biochem), Anti Histone H3 (rabbit 1:5000, Upstate) and HRP-conju-
gated secondary antibodies (anti-rabbit, Santa Cruz). Proteins were
detected with the enhanced chemiluminescence (ECL) system and
ECL Hyperﬁlm (Amersham Pharmacia Biotech).
2.9. Statistical analysis
Experimental values are expressed as mean ± S.E.M. Comparison of
mean values between various groups was performed by one-way-anal-
ysis of variance (one-way-ANOVA) followed by multiple comparisons
by Tukey test. P value <0.05 is considered to be signiﬁcant.3. Results
3.1. Eﬀect of IF on bodyweight and food intake in diabetic
animals
Despite of increased food intake in diabetic rats as compared
to controls, we did not observe the corresponding gain in
weight of diabetic animals. However, diabetic rats kept on
IF showed a slight reduction in the body weight in the earlier
weeks which may be due to sudden restriction of daily food in-
take (Fig. 1B). Total food intake was signiﬁcantly reduced in
both CIF as well as DIF groups as compared to respective
CAL and DAL which is primarily because of restricting food
(Fig. 1A).
3.2. IF inhibits the rise in blood pressure in diabetic animals
STZ induced diabetic condition is accompanied by a signif-
icant rise in blood pressure [18]. DR is reported to alleviate the
rise in blood pressure in normal conditions [24]. In order to
check whether IF plays any role in altering the hemodynamic
regulation, we have recorded blood pressure at 8th week in all
four groups by tail cuﬀ noninvasive method. DAL group
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Fig. 1A. Eﬀect of eight week IF after the induction of diabetes on food
intake. All the values are represented as mean ± S.E.M. (n = 6).
Table 2
Eﬀect of eight week IF after the induction of diabetes on the systolic
blood pressure (SBP), diastolic blood pressure (DBP) and mean
arterial blood pressure (MAP)
Group SBP (mmHg) MBP (mmHg) DBP (mmHg)
CAL 113 ± 0.72 91 ± 0.37 81 ± 0.55
CIF 114 ± 0.89 91 ± 0.49 80 ± 0.53
DAL 144 ± 2.13***a 121 ± 1.78***a 109 ± 1.25***a
DIF 112 ± 0.46***b 91 ± 0.31***b 81 ± 0.37***b
All the values are represented as mean ± S.E.M. (n = 6), ***P < 0.001.
aVs CAL.
bVs DAL.
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Fig. 1B. Eﬀect of eight week IF after the induction of diabetes on the
body weight. All the values are represented as mean ± S.E.M. (n = 6).
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blood pressure as compared to CAL. IF prevents the rise in
blood pressure in both the diabetic as well as control rats on
IF, as is evident from Table 2. Since, rise in blood pressure re-
sults in a decline in the process of glomerular ﬁltration eventu-
ally leading to nephropathic damage. IF results in prevention
to glomerular damage by decreasing the blood pressure (see
Fig. 3D).
3.3. Eﬀect of IF on plasma glucose, BUN, plasma creatinine,
plasma albumin and plasma HDL-cholesterol
After eight week of STZ treatment, we observed a signiﬁcant
increase in BUN in DAL (51 ± 4.99) as compared to CAL
(20 ± 1.80) group which indicates development of DN. How-Table 1
Eﬀect of eight week IF after the induction of diabetes on biochemical param
Group PGL (mg/dl) PCL (mg/dl) B
CAL 116 ± 6.01 1.46 ± 0.08 2
CIF 108 ± 8.75 1.41 ± 0.07 1
DAL 466 ± 40.91***a 2.04 ± 0.17**a 5
DIF 523 ± 27.26 1.41 ± 0.04**b 3
All the values are represented as mean ± S.E.M. (n = 6), ***P < 0.001, **P <
Plasma glucose level (PGL), plasma creatinine level (PCL), blood urea nitro
aVs CAL.
bVs DAL.ever, IF signiﬁcantly decreases BUN in DIF (30 ± 0.78) group
thereby preventing the progression of DN. Similarly plasma
creatinine another biomarker of DN increases signiﬁcantly in
DAL (2.04 ± 0.17) group as compared to CAL (1.46 ± 0.08),
while IF signiﬁcantly reduces the increase in plasma creatinine
in DIF (1.41 ± 0.04) group. Plasma albumin levels are lower in
DAL (2.08 ± 0.08) group in comparison to CAL (2.85 ± 0.08).
In case of DIF plasma albumin (2.4 ± 0.07) was increased sig-
niﬁcantly in comparison to DAL. So, IF protects the depletion
of albumin through urinary excretion indicating improved
functional state of nephron. Moreover, plasma HDL choles-
terol was signiﬁcantly decreased in DAL (21 ± 3.62) groups
in comparison to CAL (32 ± 0.89) group while it gets restored
to normal level in DIF (31 ± 1.48) group. However, we failed
to ﬁnd any signiﬁcant diﬀerence in plasma glucose levels be-
tween DAL and DIF group. Restoration of biochemical
parameters like BUN, plasma creatinine, plasma albumin
and plasma HDL-cholesterol of diabetic rats towards control
rat values by IF suggests its role in providing protection in pro-
gression of DN (see Table 1).
3.4. IF decreases lipid peroxidation and increases SOD level
CR is known to increase the resistance to oxidative stress
[25] and oxidative stress is one of the known culprits in the
development of nephropathy [26]. We sought to assess the lev-
els of oxidative stress markers like malondialdehyde (MDA)
and SOD. IF lowers the oxidative stress because it decreases
the lipid peroxidation and increases the SOD level. Lipid per-
oxidation signiﬁcantly increases in DAL group (382.2 ± 29.2)
as compared to CAL group (236.6 ± 9.76), while it was signi-
ﬁcantly lower in DIF group (255.83 ± 13.7). On the other side,
MDA level in DIF group was closer to CAL and CIF groups
suggesting that IF protects from oxidative stress [27] (Fig. 2A).
SOD level was signiﬁcantly decreased (50%) in DAL group
as compared to CAL which was almost reversed by IF
(Fig. 2B).eters
UN (mg/dl) PAL (g/dl) PHDL (mg/dl)
0 ± 1.80 2.85 ± 0.08 32 ± 0.89
9 ± 1.76 2.82 ± 0.07 31 ± 1.06
1 ± 4.99***a 2.08 ± 0.08***a 21 ± 3.62**a
0 ± 0.78*b 2.40 ± 0.07*b 31 ± 1.48*b
0.01 and *P < 0.05.
gen (BUN), plasma albumin level (PAL), plasma HDL level (PHDL).
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Fig. 2A. Eﬀect of eight week IF after the induction of diabetes on lipid
peroxidation. All the values are represented as mean ± S.E.M. (n = 6),
***P < 0.001 and **P < 0.01, aVs CAL and bVs DAL.
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Fig. 2B. Eﬀect of eight week IF after the induction of diabetes on SOD
level. All the values are represented as mean ± S.E.M. (n = 6),
***P < 0.001, aVs CAL and bVs DAL.
A
CAL 40X  CAL 100X
B
CIF 40 X
C
DAL 40X  DAL 100X 
D
DIF 40X   DIF 100X 
CIF 100X 
Fig. 3. Representative Mayer’s hematoxylin and eosin-stained sections
from CAL, CIF, DAL, and DIF rats. (A) In CAL rats there is less
glomerular hypertrophy, (B) CIF also shows no hypertrophy, (C)
Diabetes is associated with substantial glomerular hypertrophy and
(D) IF of diabetic rats for the eight weeks was associated with a
reduction in the extent of glomerular hypertrophy. Histopathological
changes in kidney structure were assessed in at least 25 randomly
selected tissue sections from each group studied at 40· and 100·
magniﬁcations as described in Section 2.7.
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Glomerular hypertrophy and glomerular injury is a promi-
nent feature of diabetic rats kidney. Fig. 3 represents Mayers
hematoxylin and eosin stained sections from CAL, CIF,
DAL and DIF group. Kidney section of DAL rats showed
marked microscopic changes like glomerular hypertrophy
and vacuolations compared to CAL rats (see Fig. 3A&C).
The incidence and intensity of tubular vacuolations and glo-
merular hypertrophy as well as other degenerative structures
were much lower in DIF (see Fig. 3D).
3.6. Change in expression of p38 and caspase-3 by IF in diabetic
rat kidney
It has been reported that hyperglycemic condition results in
activation of p38 [28]. It is a proapoptotic protein that plays a
pathological role in diabetic condition [13]. Our data indicates
a signiﬁcant increase in expression of p38 in DAL kidney
(Fig. 4A). However, this increase in p38 level was prevented
by IF, suggesting decrease in progression of DN. In case of
diabetic rat kidney, there is an increase in cleavage of cas-
pase-3 indicated by the appearance of 20 kDa cleaved frag-
ment (Fig. 4B) as compared to the control rat kidney.
Signiﬁcant reduction in 20 kDa cleaved caspase-3 fragment
was observed in diabetic rat kidney on IF (see Fig. 4B).3.7. IF decreases expression of p53 in diabetic rat kidney
It has been reported that under hyperglycemic conditions
expression of p53 signiﬁcantly increases in the mouse blasto-
cyst [29], and in myocytes [30]. We also observed increase in
p53 expression in diabetic kidney (Fig. 4C). Moreover, our
data shows that IF results in a marked reduction in the expres-
sion of p53 in diabetic kidney (Fig. 4C).
3.8. IF in diabetic rats increases Sir2 activity
The yeast Sir2 gene appears to promote survival in a wide
range of organism and the mammalian ortholog of Sir2, sirtu-
ins, represses the activity of p53 and therefore inhibits apopto-
sis. It has been shown that p53 is deacetylated and its
expression is downregulated by Sir2. Thus, Sir2 negatively reg-
ulates p53 dependent apoptosis in response to cellular damage
[31–33]. Fig. 4C shows Sir2 expression by Western blot analy-
sis of IF diabetic rat kidney. Our result clearly shows that there
is decrease in expression of Sir2 in DAL rat kidney (Fig. 4C,
lane c). IF signiﬁcantly increases its expression in DIF
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Fig. 4. Eﬀect of IF on the expression of p38, cleaved caspase3, Sir2, p53 and phosphorylated histone H3 (Ser-10) in diabetic rat kidneys. Western blot
analysis of caspase-3 and p38 in kidney homogenates and Sir2, p53 and p-histone H3 in total nuclear extracts from rat kidneys as described in Section
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working at two levels, on one hand it is reducing p53 expres-
sion and on the other hand it is also preventing its activation
by activating deacetylating enzyme Sir2.
3.9. Change in histone H3 phosphorylation by IF in diabetic rat
kidney
Activation of p38 under diabetic condition suggested us to
look for downstream signaling molecules that result into mod-
ifying chromatin structure. Phosphorylation of histone H3 at
serine 10 occurs usually when cells enters into mitosis [34]. Sev-
eral toxicants have also been shown to induce histone H3
phosphorylation, which results into premature chromatin con-
densation and cell death [35]. Fig. 4D shows dephosphoryla-
tion of histone H3 under diabetic condition. However, IF to
diabetic animals prevents histone H3 dephosphorylation. This
change in histone H3 phosphorylation can only be explained ifwe assume that IF either directly or indirectly prevents cells to
undergo mitotic arrest.4. Discussion
Neuroprotective eﬀect of IF studies have reported that IGF-
1 signaling is involved in experimental models of neurodegen-
erative disorders [36,37]. However, there are no reports, till
date, pertaining to the role of IF in DN and the mechanisms
involved therein. IF results in a signiﬁcant decrease in BUN
and plasma creatinine levels after the 8 weeks of induction of
diabetes. Rats on IF also show increased plasma albumin as
well as HDL-cholesterol.
Chronic hyperglycemia increases oxidative stress and con-
siderably modiﬁes the structure and function of proteins and
lipids, due to glycoxidation and peroxidation [38,39]. These
1076 K. Tikoo et al. / FEBS Letters 581 (2007) 1071–1078modiﬁed products could contribute to the morphological and
functional abnormalities to the blood vessels as well as kidney
which may lead to increase in blood pressure. If this persists
for a longer time, it may lead to kidney failure. We observed
increase in blood pressure in STZ induced diabetic rat after
eight weeks of induction of diabetes. These DAL rats showed
signiﬁcant increase in mean, systolic and diastolic blood pres-
sure as compared to CAL. Moreover eight weeks of IF results
in a signiﬁcant decrease in mean systolic and diastolic blood
pressure.
Oxidative stress has been suggested extensively as a potential
mechanism for diabetic kidney disease because it promotes the
formation lipid peroxidation products and decreases the anti-
oxidant defense by decreasing the level of antioxidant enzymes
like SOD, catalase and glutathione. The importance of oxida-
tive stress in pathology is dependent on both its sources and its
targets. In diabetes, hyperglycemia has been considered as the
major culprit of oxidative stress induced damage inﬂicted on
the various tissues including kidney leading to the development
of diabetic nephropathy [26]. Remarkably, IF resulted in a sig-
niﬁcant increase in the SOD levels in the kidneys of diabetic
rats. The MDA levels are also found to be reduced signiﬁ-
cantly in the diabetic rats on IF.
Recently, Sir2 gene was reported to be downregulated in the
skeletal muscles of conditional knockout muscle insulin recep-
tor knockout (MIRKO) mice [40]. We found decrease in level
of Sir2 in diabetic kidney and IF prevents this decrease. These
results further implicate this enzyme as a putative molecular
marker of nephropathic condition. Although, the mechanisms
of its down regulation in diabetic conditions are not till yet
clear.
Sirtuins target many proteins that are not histones they have
been demonstrated to bind and deacetylate p53 in vitro and
in vivo [32,33,41]. p53 is transcriptional activator, and its acti-
vation results in cell cycle arrest, senescence or the initiation of
programmed cell death. Over expression of sirtuins has been
shown to inhibit p53-dependent apoptosis in response to
DNA damage and oxidative stress [33]. Recently, it has beenp3
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proposed).reported that increased expression of p53 gene under diabetic
condition is associated with renal apoptosis [42]. We found in-
creased expression of p53 protein in the kidneys of diabetic
animals as compared to their respective controls. However,
the expression of p53 is reduced signiﬁcantly in the kidneys
of diabetic rats on IF regimen. The expression as well as acti-
vation of p53 is thought to be mediated by Sir2 dependent
deacetylation. They both share an inverse relationship as is evi-
dent from our results wherein the Sir2 expression is decreased
and at the same time p53 is upregulated.
Attenuation of p53 expression in diabetic rats kept on IF
regimen indicts the involvement of anti apoptotic cascades.
Since caspase activation forms the mainstay of apoptotic
events, therefore we evaluated the cleavage of caspase-3 in dia-
betic kidney. Caspases when activated initiate a cascade of
events leading to cleavage of PARP and self autolysis resulting
in the appearance of a 20 kDa fragment signifying apoptosis.
Recently Susztak et al. [13] have demonstrated that activation
of caspases-3 and p38 are involved in podocyte apoptosis dur-
ing the onset of diabetic nephropathy. Our data also shows
that cleaved 20 kDa fragment is markedly reduced in the kid-
ney of diabetic rats kept on IF. Although the mechanism by
which IF exerts its anti apoptotic eﬀects is yet to be understood
in detail but the decrease in caspase-3 cleavage by IF and also
suppression and activation of p53 and Sir2, respectively. Sug-
gest a cross talk between Sir2, p53 and caspase-3.
Stress activated protein kinase p38 is also known to be acti-
vated under diabetic conditions [28,43] and the role of p38 is
well documented as an upstream mediator of apoptotic cell
death. Interestingly, the expression of p38 is increased in the
diabetic rat kidney which got deceased by IF. Activation of
p38 MAPK pathway is known to induce phosphorylation of
histone H3 [44]. However, we observed decrease in histone
H3 phosphorylation (Ser-10) in the diabetic rat kidney. Inter-
estingly, this decrease in phosphorylation of histone H3 is pre-
vented in the kidneys of rat on IF. Phosphorylation of histone
H3 at Ser10 facilitates the transcription of immediate early
genes [45–49], whereas during mitosis such phosphorylationHyperglycemia
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Hendzel et al. [53] have shown that, phosphorylation of H3
and apoptotic chromosome condensation are unrelated events
and chromosome condensation can occur without phosphory-
lation of Ser-10. Thus, decrease in histone H3 phosphorylation
under diabetic condition can not suggest that cells are getting
prevented against apoptotic cell death. However, these results
signify the regulatory role of histone phosphatases and histone
kinases in diabetic conditions. The increase in phosphorylation
of histone H3 in IF might be due to speciﬁc inhibition of his-
tone phosphatases or activation of histone kinases. Our data
provides indirect evidence that IF increases phosphorylation
of histone H3 which is not histone kinase dependent rather it
is histone phosphatase dependent. This can be explained if
we assume histone kinases are activated by upstream kinase
p38. However during IF, expression of p38 is downregulated
(see Fig. 5).
In conclusion, we demonstrate the nephroprotective eﬀect of
IF in diabetes. Although the precise mechanisms leading to
activation of Sir2 and downregulation of proapoptotic p53
in IF are yet to be understood in detail, but these results def-
initely underscore the role of dietary regimens in pathophysio-
logical condition.
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